Status:
COMPLETED
Relationship Between Metabolic Profile and Clinical Phenotype in Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Peking University Third Hospital
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
MALE
40-80 years
Brief Summary
Despite the high prevalence of chronic obstructive pulmonary disease (COPD), there continues to be a large gap in our understanding of disease pathogenesis and mechanisms accounting for large variabil...
Detailed Description
Despite the high prevalence of chronic obstructive pulmonary disease (COPD), there continues to be a large gap in our understanding of disease pathogenesis and mechanisms accounting for large variabil...
Eligibility Criteria
Inclusion
- I
- males aged 40-80;
- diagnosed with COPD according to the GOLD guidelines;
- clinically stable patients without medication changes or exacerbation in two months;
- smoking history of more than 10 pack years
Exclusion
- diagnosed with unstable cardiovascular diseases, significant renal or hepatic dysfunction or mental incompetence;
- diagnosed with asthma, active pulmonary tuberculosis, diffuse panbronchiolitis, cystic fibrosis, clinically significant bronchiectasis, exacerbation of COPD or pneumonia in two months;
- prescribed immunosuppressive medications.
Key Trial Info
Start Date :
December 10 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 20 2017
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT03310177
Start Date
December 10 2015
End Date
July 20 2017
Last Update
October 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191